Health Canada uses the hotlist to indicate restrictions and prohibitions of certain substances for use in cosmetics. On May 3, 2019, Health Canada opened a consultation on several updates of the Cosmetic Ingredient Hotlist. The scope of the
Skincare products containing cannabis are growing in popularity. Cannabis derivatives have become trendy ingredients for cosmetics manufacturers. Let’s have a brief look at the current regulatory status of this popular cosmetic ingredient in Canada. Cannabinoids come from three
The FDA has announced today that it seeks public comments on a proposed consumer survey about allergens in cosmetics! Cosmetics are a broad category that includes items such as fragrances, hair products, makeup, nail products, and skin care
It’s this time of the year again: sun protection is on everyone’s lips… including regulatory agencies! For instance, the FDA has multiplied its efforts to ensure consumers’ protection by sending warning letters to companies that mislead consumers by
Sunscreens are back on store shelves and consumers debate to choose the best formula. As we all know, two categories of sunscreen, differing on their distinct mode of action, are available: Chemical sunscreen: composed of organic molecules that
Product claims communicate the benefits of a cosmetic product to the consumers. They can be found on product packaging, labeling or any other form of advertisement including brochures, television or website. Regulatory agencies such as the FTC (Federal
The FDA has been extremely active last month and they are keeping a close eye on cosmetic manufacturers that make drug claims. Terms such as inflammation, oxidation, genes – anything that mention changes to the body – will be
Manufacturers and distributors of personal care and cosmetic products are responsible for ensuring that their products and ingredients are safe. In addition, they must be able to demonstrate proofs of performance claims and they must correctly label their
The FDA has extended its international operation model and now provides key regulatory laws and practices in multiple languages. This will also enable the industry and FDA’s foreign counterparts to better understand the agency’s laws and practices. Reference
The ethics and scientific quality of human clinical trials is regulated by international standards set by the International Conference on Harmonization (ICH) in the form of guidelines known as Good Clinical Practice (GCP). These guidelines are accepted worldwide